Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan

Karmanos Cancer Institute at McLaren Greater Lansing is a clinical research site located in Lansing, Michigan, United States 48910.

Crixeo Clinical Trials Trust Score: 29/100 (FAILING). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute at McLaren Greater Lansing has participated in 67 clinical trials with 54 currently active.

Therapeutic areas: Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Canal Squamous Cell Carcinoma.

Sponsors: ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lansing

Browse all research sites in Michigan · View every site in Lansing

• Michigan State University Department of Surgery
• Sparrow Health System - Sparrow Hospital
• Bresline Cancer Center at Michigan State University
• Herbert Herman Cancer Center, Sparrow Hospital
• University of Michigan Health Sparrow
• Michigan State University Infectious Diseases Clinic
• Sparrow Hospital
• E.W Sparrow Hospital
• Michigan State University
• Sparrow Hospital / Sparrow Medical Group
• Michigan State University/Breslin Cancer Center
• Great Lakes Cancer Institute - Michigan State University

Sponsor Feasibility Report

Trust Score: 29/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute at McLaren Greater Lansing?

Karmanos Cancer Institute at McLaren Greater Lansing has a Crixeo Trust Score of 29/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute at McLaren Greater Lansing conducted?

Karmanos Cancer Institute at McLaren Greater Lansing has 67 clinical trials on record, with 54 currently active. Their work covers Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Canal Squamous Cell Carcinoma.

Is Karmanos Cancer Institute at McLaren Greater Lansing accredited by Crixeo Clinical Trials?

Karmanos Cancer Institute at McLaren Greater Lansing has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute at McLaren Greater Lansing?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.